Spastic ataxias.

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• Spasticity and pyramidal signs are characteristic of hereditary ataxias like autosomal-recessive spastic ataxia of Charlevoix-Saguenay, Friedreich ataxia, and vitamin E deficiency.
• Spastic paraplegias, such as spastic paraplegia 7, can mimic ataxia and share pathophysiological links with cerebellar ataxias.
• The rarity and genetic heterogeneity of these conditions complicate molecular diagnosis.

Purpose of the Study:

• To review the clinical, epidemiologic, and genetic features of well-defined spastic ataxias.
• To highlight autosomal-recessive spastic ataxia of Charlevoix-Saguenay as a frequent, early-onset spastic ataxia.
• To discuss differential diagnosis for spastic ataxia, including secondary causes in genetic/metabolic disorders.

Main Methods:

• Literature review of clinical, epidemiologic, and genetic data.
• Focus on distinguishing features of various spastic ataxias.
• Emphasis on age of onset and key clinical/imaging findings.

Main Results:

• Autosomal-recessive spastic ataxia of Charlevoix-Saguenay is a significant cause of early-onset spastic ataxia worldwide.
• Differential diagnosis requires careful consideration of clinical presentation, onset age, and specific genetic/metabolic profiles.
• Shared pathways exist between spastic paraplegias with ataxic features and cerebellar ataxias.

Conclusions:

• Accurate molecular diagnosis of spastic ataxias is challenging but crucial.
• Understanding the distinct clinical and genetic profiles aids in differentiating these rare neurological disorders.
• Early-onset spastic ataxia requires comprehensive evaluation to identify underlying genetic causes.